| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060177543 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | DE102005005399A1 Use of 2,4-dihydroxy-3-methylbenzoate derivatives for preparing medicaments or as basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596618A1 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688141A1 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687259A1 Cyclopentyl derivates |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1687006A1 Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
| 08/09/2006 | EP1686994A2 Use of dipeptidyl peptidase iv inhibitors |
| 08/09/2006 | EP1686985A2 Use of neurokinin antagonists in the treatment of urinary incontinence |
| 08/09/2006 | EP1472249B1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1179346B1 Remedies for glomerulosclerosis |
| 08/09/2006 | EP1178782B1 Transdermal therapeutic system (tts) containing tolterodine |
| 08/09/2006 | EP1148881B1 USE OF PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816344A Herbal compositions for the treatment and prevention of prostate disorders |
| 08/09/2006 | CN1814244A Chinese medicine suppository for treating liver fiberosis and hysteromyoma and preparing method |
| 08/09/2006 | CN1814221A Chinese medicine composition for treating urethra infection and preparing method |
| 08/09/2006 | CN1814219A Liquid capsule for treating urinary system infection and preparing method |
| 08/09/2006 | CN1814193A Chinese meidine composition for treating nephritis dropsy and use thereof |
| 08/09/2006 | CN1814171A Medicine for treating renal incompetence |
| 08/09/2006 | CN1814149A Medicine composition for treating diabetes or diabetes kidney-disease, and preparing method |
| 08/09/2006 | CN1814127A Shenbao preparation, its preparing method and quality control method |
| 08/09/2006 | CN1814124A Rehmannia-root preparation of nourishing Yin, supplementing kidney and Qi, activating blood circulation |
| 08/09/2006 | CN1814119A Yougui capsule |
| 08/09/2006 | CN1814090A Niaoduqing medicine preparation and preparing method |
| 08/09/2006 | CN1814076A Chinese medicine composition new use |
| 08/09/2006 | CN1814074A Medicine for treating chronic prostatitis of damp-heat congestion type and hyperplasia of prostate |
| 08/09/2006 | CN1814073A Qianliean medicine preparation and preparing method |
| 08/09/2006 | CN1814039A Medicine for treating prostate disease |
| 08/09/2006 | CN1814011A Medicine composition for treating upper respiratory tract inflammation, preparing method, quality control method and use |
| 08/09/2006 | CN1814007A Yankening medicine preparation and its preparing method |
| 08/09/2006 | CN1813932A Medicinal formulation for treating kidney stone and its preparing method |
| 08/09/2006 | CN1813924A Eight-ingredient amur barberry bark capsule |
| 08/09/2006 | CN1813908A Chinese medicine for treating nephroma and its use |
| 08/09/2006 | CN1813896A Chinese medicine formulation for treating nephroma, and its preparing method and quality control method |
| 08/09/2006 | CN1813867A Astragalus mongholicus tablet, and its preparation and active constituent content measuring method |
| 08/09/2006 | CN1813862A Chinese medicine composition for treating chyluria and its use |
| 08/09/2006 | CN1813830A Chinese medicine formulation for treating calculuses |
| 08/09/2006 | CN1813758A Levofloxacin hydrochloride micro-pill capsule and its preparing method |
| 08/09/2006 | CN1813741A Medicinal composition containing amlodipine and terazosine |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1813680A Isepamicin sulfate powder for injection and its preparing method |
| 08/09/2006 | CN1813673A Isepamicin sulfate formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1813555A Substituted tea for clearing heat, relieving summer heat, removing alcohol, diuresis and relieving struct and its production method |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268395C Remedies for chronic kidney diseases |
| 08/09/2006 | CN1268383C Medicinal composition for treating nephropathy |
| 08/09/2006 | CN1268371C Chinese medicinal compound preparation for treating prostate hyperplasia and preparing process thereof |
| 08/09/2006 | CN1268370C Capsules for nourishing kidney and strengthening yang |
| 08/09/2006 | CN1268352C Prostate hyperplasia treating medicine by fatsoluble active constituent of winged euony twigs and its preparation process |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268332C Kappa opiate agonists for treatment of bladder diseases |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087619 Method for the treatment of urinary incontinence |
| 08/08/2006 | US7087608 Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087241 Administering a transmucosal formulation, comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1, wherein the transmucosal formulation optionally includes a permeation enhancer |
| 08/08/2006 | US7087223 Preventives and/or remedies for hyperphosphatemia |
| 08/08/2006 | CA2358938C Methods for assessing, improving, or maintaining urogenital health in postmenopausal women |
| 08/03/2006 | WO2006080828A1 Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts |
| 08/03/2006 | WO2006080477A1 Norvaline derivative and method for preparation thereof |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080415A1 Composition and method for treating or preventing bladder disorder |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006079559A2 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |